201 related articles for article (PubMed ID: 36890422)
1. Promotion of ferroptosis in head and neck cancer with divalent metal transporter 1 inhibition or salinomycin.
Lee J; Roh JL
Hum Cell; 2023 May; 36(3):1090-1098. PubMed ID: 36890422
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Glutaredoxin 5 predisposes Cisplatin-resistant Head and Neck Cancer Cells to Ferroptosis.
Lee J; You JH; Shin D; Roh JL
Theranostics; 2020; 10(17):7775-7786. PubMed ID: 32685019
[No Abstract] [Full Text] [Related]
3. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis.
Roh JL; Kim EH; Jang H; Shin D
Redox Biol; 2017 Apr; 11():254-262. PubMed ID: 28012440
[TBL] [Abstract][Full Text] [Related]
4. Dihydrolipoamide dehydrogenase regulates cystine deprivation-induced ferroptosis in head and neck cancer.
Shin D; Lee J; You JH; Kim D; Roh JL
Redox Biol; 2020 Feb; 30():101418. PubMed ID: 31931284
[TBL] [Abstract][Full Text] [Related]
5. DMT1 Inhibitors Kill Cancer Stem Cells by Blocking Lysosomal Iron Translocation.
Turcu AL; Versini A; Khene N; Gaillet C; Cañeque T; Müller S; Rodriguez R
Chemistry; 2020 Jun; 26(33):7369-7373. PubMed ID: 32083771
[TBL] [Abstract][Full Text] [Related]
6. Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer.
Shin D; Kim EH; Lee J; Roh JL
Free Radic Biol Med; 2018 Dec; 129():454-462. PubMed ID: 30339884
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic reprogramming of epithelial-mesenchymal transition promotes ferroptosis of head and neck cancer.
Lee J; You JH; Kim MS; Roh JL
Redox Biol; 2020 Oct; 37():101697. PubMed ID: 32896720
[TBL] [Abstract][Full Text] [Related]
8. Poly(rC)-binding protein 1 represses ferritinophagy-mediated ferroptosis in head and neck cancer.
Lee J; You JH; Roh JL
Redox Biol; 2022 May; 51():102276. PubMed ID: 35290903
[TBL] [Abstract][Full Text] [Related]
9. Hepcidin Promoted Ferroptosis through Iron Metabolism which Is Associated with DMT1 Signaling Activation in Early Brain Injury following Subarachnoid Hemorrhage.
Zhang H; Ostrowski R; Jiang D; Zhao Q; Liang Y; Che X; Zhao J; Xiang X; Qin W; He Z
Oxid Med Cell Longev; 2021; 2021():9800794. PubMed ID: 34987706
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia regulates the ferrous iron uptake and reactive oxygen species level via divalent metal transporter 1 (DMT1) Exon1B by hypoxia-inducible factor-1.
Wang D; Wang LH; Zhao Y; Lu YP; Zhu L
IUBMB Life; 2010 Aug; 62(8):629-36. PubMed ID: 20681027
[TBL] [Abstract][Full Text] [Related]
11. Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer.
Roh JL; Kim EH; Jang HJ; Park JY; Shin D
Cancer Lett; 2016 Oct; 381(1):96-103. PubMed ID: 27477897
[TBL] [Abstract][Full Text] [Related]
12. CISD2 inhibition overcomes resistance to sulfasalazine-induced ferroptotic cell death in head and neck cancer.
Kim EH; Shin D; Lee J; Jung AR; Roh JL
Cancer Lett; 2018 Sep; 432():180-190. PubMed ID: 29928961
[TBL] [Abstract][Full Text] [Related]
13. Temozolomide Drives Ferroptosis via a DMT1-Dependent Pathway in Glioblastoma Cells.
Song Q; Peng S; Sun Z; Heng X; Zhu X
Yonsei Med J; 2021 Sep; 62(9):843-849. PubMed ID: 34427071
[TBL] [Abstract][Full Text] [Related]
14. Dynasore Blocks Ferroptosis through Combined Modulation of Iron Uptake and Inhibition of Mitochondrial Respiration.
Clemente LP; Rabenau M; Tang S; Stanka J; Cors E; Stroh J; Culmsee C; von Karstedt S
Cells; 2020 Oct; 9(10):. PubMed ID: 33050207
[TBL] [Abstract][Full Text] [Related]
15. Site-specific intestinal DMT1 silencing to mitigate iron absorption using pH-sensitive multi-compartmental nanoparticulate oral delivery system.
Fan Y; Dhaliwal HK; Menon AV; Chang J; Choi JE; Amiji MM; Kim J
Nanomedicine; 2019 Nov; 22():102091. PubMed ID: 31626992
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-6 promotes ferroptosis in bronchial epithelial cells by inducing reactive oxygen species-dependent lipid peroxidation and disrupting iron homeostasis.
Han F; Li S; Yang Y; Bai Z
Bioengineered; 2021 Dec; 12(1):5279-5288. PubMed ID: 34402724
[TBL] [Abstract][Full Text] [Related]
17. Benefits of Iron Chelators in the Treatment of Parkinson's Disease.
Zeng X; An H; Yu F; Wang K; Zheng L; Zhou W; Bao Y; Yang J; Shen N; Huang D
Neurochem Res; 2021 May; 46(5):1239-1251. PubMed ID: 33646533
[TBL] [Abstract][Full Text] [Related]
18. Sulfasalazine‑induced ferroptosis in breast cancer cells is reduced by the inhibitory effect of estrogen receptor on the transferrin receptor.
Yu H; Yang C; Jian L; Guo S; Chen R; Li K; Qu F; Tao K; Fu Y; Luo F; Liu S
Oncol Rep; 2019 Aug; 42(2):826-838. PubMed ID: 31173262
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of divalent metal transporter 1 in 6-hydroxydopamine intoxication is IRE/IRP dependent.
Jiang H; Song N; Xu H; Zhang S; Wang J; Xie J
Cell Res; 2010 Mar; 20(3):345-56. PubMed ID: 20125122
[TBL] [Abstract][Full Text] [Related]
20. Canonical Wnt signaling works downstream of iron overload to prevent ferroptosis from damaging osteoblast differentiation.
Luo C; Xu W; Tang X; Liu X; Cheng Y; Wu Y; Xie Z; Wu X; He X; Wang Q; Xiao Y; Qiu X; Tang Z; Shao G; Tu X
Free Radic Biol Med; 2022 Aug; 188():337-350. PubMed ID: 35752374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
